1. HOME
2. Research Insight
3. 3M Company (US) and Asahi-kasei Corporation (Japan) are Leading Players in the Temperature Management Systems Market

The global temperature management systems market is projected to reach USD 3.9 Billion by 2028 from USD 3.0 Billion in 2023, at a CAGR of 4.9% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of chronic and infectious diseases, the rising number of surgical procedures, and the increasing number of hypothermia cases.

The temperature management systems market is consolidated and is dominated by various players. The major players operating in this market are 3M Company (US), Asahi-kasei Corporation (Japan), Becton, Dickinson and Company (US), GE Healthcare (US) and Dragerwerk AG & Co. KGAA (Germany). These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities further to expand their presence in the temperature management systems Market.

To know about the assumptions considered for the study download the pdf brochure

3M Company (US)

3M company offers products under four operating business segment i.e. Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. It offers temperature management solutions through its Health Care division. The Health Care Business Group serves markets that include Food Safety, Health Information Systems, Medical Solutions, Oral Care, Separation and Purification Sciences, and Other Health Care. Temperature management systems are offered through the Medical Solutions segment.  The company has operations in the US, the Asia Pacific, Europe, the Middle East and Africa (EMEA), Latin America, and Canada. Some of its major subsidiaries include 3M Australia Pty. Ltd., 3M Health Information Systems, Inc. (US), 3M China Limited, and 3M United Kingdom plc (UK). Therefore in December 2022, The company was a named defendant in approximately 5,258 lawsuits in the United States and one Canadian putative class action with a single named plaintiff, alleging that the Bair Hugger patient warming system caused surgical-site infections.

Asahi-kasei Corporation (Japan)

Asahi Kasei is a diversified manufacturer with operations in four business segments—Material, Homes, Healthcare, and Others. The Healthcare business is further segmented into Pharmaceuticals, Medical Care, and Acute Critical Care. ZOLL Medical is a subsidiary of Asahi Kasei Corporation through which company offers the wide range of temperature management systems. ZOLL Medical takes care of the company’s Healthcare business. The company develops and markets medical devices and software solutions to aid in the advancement of emergency care and increase clinical and operational efficiencies..  For Instance, In July 2023, The company signed an agreement with BrainCool, a medical device company specializing in temperature management solutions, for the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the US and key markets in Europe. The companies are working toward expanding distribution to select markets in Asia.

Becton, Dickinson and Company (US)

Becton, Dickinson and Company is a medical technology company engaged in the manufacturing and sale of medical devices, instrument systems, and reagents. In 2017, BD entered the temperature management systems market through the acquisition of C. R. Bard (US). BD operates through three key business segments: BD Medical, BD Life Science, and BD Interventional. C. R. Bard’s product offerings are included in the BD Interventional and BD Medical segments. The company operates in more than 190 countries across North America, Europe, and Greater Asia. Some of its major subsidiaries include Atto BioScience, Inc. (US), AutoCyte Australia Pty Ltd., AutoCyte NC, LLC (US), BD Ophthalmic Systems Limited (UK), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), Becton Dickinson Advanced Pen Injection Systems GmbH (Switzerland), Becton Dickinson Infusion Therapy B.V. (Netherlands), Becton Dickinson India Private Limited, and Becton Dickinson France S.A.S.

GE Healthcare (US)

GE is a diversified infrastructure and financial services company which operates through four business segments—Power, Renewable Energy, Aviation, and Healthcare. The Healthcare segment offers healthcare technologies in medical imaging, digital solutions, patient monitoring and diagnostics, drug discovery, biopharmaceutical manufacturing technologies, and performance enhancement solutions. On January 3, 2023, GE completed the previously announced separation of its HealthCare business into a separate, independent, publicly traded company.  GE’s business is spread across 170 countries in North America, Europe, Asia, and South America. Some of its subsidiaries are GE Healthcare Finland Oy (Finland), GE Healthcare Holding Norge AS (Norway), GE Healthcare Life Sciences Holding AB (UK), GE Healthcare Sweden Holding AB (Sweden), GE Media Holdings, Inc. (US), and GE Healthcare Bio-Sciences AB (Belgium).

Dragerwerk AG & Co. KGAA (Germany)

Drägerwerk is one of the leading companies in the field of medical and safety technology. The company operates through two business segments—Medical Division and Safety Division. The company offers temperature management products through its Medical Division segment.  The Medical Business segment is divided into five business units—Therapy (Anesthesia Devices and Ventilators as well as Thermoregulation Equipment), Hospital Consumables & Accessories (Generic and Device-specific Consumables and Accessories), Workplace Infrastructure (Supply Units, Lights, and Gas Management Systems), Monitoring (Patient Monitoring), and IT & Systems (Software Applications, System Products, and New Services).

The company is present in over 190 countries across Europe, the Americas, Africa, Asia, and Australia. Drägerwerk maintains sales and service organizations in over 50 countries and has development and production facilities in Germany, the UK, Norway, Sweden, South Africa, the US, Brazil, Chile, the Czech Republic, and China. For Instance, Drager has launched the FDA-cleared Babyroo TN300, a new open warmer that offers supportive lung protection and temperature stability from the moment of birth through discharge home. It is designed to give clinicians the access they need for regular care, emergencies, and procedures throughout the baby’s stay in the hospital while also supporting family-centered care, which is critical to healthy outcomes.

Related Reports:

Temperature Management Systems Market by Product (Warming Systems (Surface, Intravascular), Cooling Systems, Application (Perioperative, Acute, Newborn Care), Medical Speciality (Cardiology, Neurology, Pediatrics, Orthopedics) - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]